Irish company’s Vascepa on track for earlier than expected approval

Group beats €100m target and intends to invest the bulk of the fund in Europe and US

Stock advances over fivefold in 12 months on evidence of medicine’s cardiovascular effect

Clinical trials show Irish company’s fish-oil drug cut incidence of heart attacks and strokes

The Republic’s largest hotel group has more than 9,000 rooms across its portfolio

Stripe, Dalata, Glanbia and Amarin shortlisted on back of standout years

The last 12 months proved to be another year of mixed fortunes in corporate Ireland

Some concern over neutrality of placebo and whether it might have boosted Vascepa data

‘Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk

After several false starts, way is clear for John Thero to take Vascepa cholesterol drug to market

Company’s Vascepa drug proves effective in reducing risk from stroke and heart attack

Varadkar backs Minister’s consent granted to O’Brien to take up board role at US firm

Irish biotech’s drug used to treat US patients with high levels of blood fats

There are thousands of getaways waiting to be explored. Here are some ideas to get you started

Company targets expanded market share for fish oil drug that cuts risk of heart disease

Costs, including ongoing R&D, means the company reports loss of $21.9 million for the quarter and $115.2 million for full year

Irish pharma firm wins major victory over FDA on off-label promotion of its drug Vascepa

US court rules regulator cannot bar company promoting off label use for drug

Small Irish pharma group sues US regulator over restricting its right to free speech

Dublin group says regulator refusal to allow it discuss off label use breaches US first amendment rights and puts it at a disadvantage to rival unregulated products